{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:02:12Z","timestamp":1775570532068,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"DOI":"10.7759\/cureus.102975","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:25:49Z","timestamp":1770229549000},"source":"Crossref","is-referenced-by-count":1,"title":["A Rare Case of Fluoxetine-Induced Vortex Keratopathy"],"prefix":"10.7759","author":[{"given":"Soumya","family":"Behera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhangi","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somya","family":"Pilani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apoorva","family":"V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2016.11.008","article-title":"Drug-induced corneal epithelial changes","volume":"62","author":"Raizman MB","year":"2017","unstructured":"Raizman MB, Hamrah P, Holland EJ, Kim T, Mah FS, Rapuano CJ, Ulrich RG. Drug-induced corneal epithelial changes. Surv Ophthalmol. 2017, 62:286-301. 10.1016\/j.survophthal.2016.11.008","journal-title":"Surv Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001913","article-title":"Transient cornea verticillata of unknown etiology: a case report","volume":"38","author":"Koh S","year":"2019","unstructured":"Koh S, Hamano T, Ichii M, Yatsui K, Maeda N, Nishida K. Transient cornea verticillata of unknown etiology: a case report. Cornea. 2019, 38:e16-7. 10.1097\/ICO.0000000000001913","journal-title":"Cornea"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05379-7","article-title":"Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials","volume":"260","author":"Wu JH","year":"2022","unstructured":"Wu JH, Chang SN, Nishida T, Kuo BI, Lin JW. Intraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trials. Graefes Arch Clin Exp Ophthalmol. 2022, 260:937-48. 10.1007\/s00417-021-05379-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.01.473","article-title":"Vortex keratopathy associated with long-term use of amiodarone","volume":"115","author":"Altun S","year":"2015","unstructured":"Altun S, Yolcu U, Ilhan A, Guler A, Sahin MA, Cingoz F. Vortex keratopathy associated with long-term use of amiodarone. Am J Cardiol. 2015, 115:148. 10.1016\/j.amjcard.2015.01.473","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm1406501","article-title":"Images in clinical medicine. Amiodarone-induced vortex keratopathy","volume":"372","author":"Chan TC","year":"2015","unstructured":"Chan TC, Jhanji V. Images in clinical medicine. Amiodarone-induced vortex keratopathy. N Engl J Med. 2015, 372:1656. 10.1056\/NEJMicm1406501","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(14)72216-0","article-title":"Vortex keratopathy associated with atovaquone","volume":"120","author":"Shah GK","year":"1995","unstructured":"Shah GK, Cantrill HL, Holland EJ. Vortex keratopathy associated with atovaquone. Am J Ophthalmol. 1995, 120:669-71. 10.1016\/s0002-9394(14)72216-0","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/10781552221101799","article-title":"Vortex keratopathy associated with ribociclib","volume":"29","author":"T\u00fcrkel A","year":"2023","unstructured":"T\u00fcrkel A, \u00d6zdo\u011fan S, Yeked\u00fcz E, \u015eeyran E, Kara\u00e7in C, Ate\u015f \u00d6. Vortex keratopathy associated with ribociclib. J Oncol Pharm Pract. 2023, 29:230-2. 10.1177\/10781552221101799","journal-title":"J Oncol Pharm Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2011.25.5.355","article-title":"Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer","volume":"25","author":"Ahn J","year":"2011","unstructured":"Ahn J, Wee WR, Lee JH, Hyon JY. Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer. Korean J Ophthalmol. 2011, 25:355-7. 10.3341\/kjo.2011.25.5.355","journal-title":"Korean J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04043-6","article-title":"CDK4\/6 inhibitor-associated vortex keratopathy: a case report","volume":"25","author":"Shu L","year":"2025","unstructured":"Shu L, Cui X, Wang Y, Sun X. CDK4\/6 inhibitor-associated vortex keratopathy: a case report. BMC Ophthalmol. 2025, 25:206. 10.1186\/s12886-025-04043-6","journal-title":"BMC Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101661","article-title":"Raloxifene induced keratopathy: a case report","volume":"27","author":"Park JM","year":"2022","unstructured":"Park JM, Jeong KD, Kang MJ, Lee JH, Kim JS, Hwang JH. Raloxifene induced keratopathy: a case report. Am J Ophthalmol Case Rep. 2022, 27:101661. 10.1016\/j.ajoc.2022.101661","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_2415_23","article-title":"Netarsudil-associated vortex keratopathy","volume":"4","author":"Lakra S","year":"2024","unstructured":"Lakra S, Priya S, Haokip GL. Netarsudil-associated vortex keratopathy. Indian J Ophthalmol Case Rep. 2024, 4:321-2. 10.4103\/IJO.IJO_2415_23","journal-title":"Indian J Ophthalmol Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.25259\/IJPP_52_2024","article-title":"Hydroxychloroquine-induced reversible keratopathy in a coronavirus disease 2019 patient: a case report","volume":"68","author":"Khanavkar RP","year":"2024","unstructured":"Khanavkar RP, Kanade-Sable A, Tamboli SB, Hannan A. Hydroxychloroquine-induced reversible keratopathy in a coronavirus disease 2019 patient: a case report. Indian J Pharmacol. 2024, 68:243-5. 10.25259\/IJPP_52_2024","journal-title":"Indian J Pharmacol"},{"key":"ref13","article-title":"Vortex keratopathy","volume":"13","author":"Arya S","year":"2025","unstructured":"Arya S, Abbasi S, Saxena S. Vortex keratopathy. UP J Ophthalmol. 2025, 13:71-3.","journal-title":"UP J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13060904","article-title":"Ophthalmic manifestations in Fabry disease: updated review","volume":"13","author":"Gambini G","year":"2023","unstructured":"Gambini G, Scartozzi L, Giannuzzi F, et al.. Ophthalmic manifestations in Fabry disease: updated review. J Pers Med. 2023, 13:904. 10.3390\/jpm13060904","journal-title":"J Pers Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314906","article-title":"Fabry keratopathy: manifestations and changes over time","volume":"104","author":"Sivley MD","year":"2020","unstructured":"Sivley MD, Benjamin WJ. Fabry keratopathy: manifestations and changes over time. Br J Ophthalmol. 2020, 104:1148-55. 10.1136\/bjophthalmol-2019-314906","journal-title":"Br J Ophthalmol"},{"key":"ref16","article-title":"Vortex keratopathy in a patient with multiple myeloma","volume":"16","author":"Chong E-M","year":"1997","unstructured":"Chong E-M, Campbell RJ, Bourne WM. Vortex keratopathy in a patient with multiple myeloma. Cornea. 1997, 16:592-4.","journal-title":"Cornea"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S49283","article-title":"Cloudy corneas as an initial presentation of multiple myeloma","volume":"8","author":"Sharma P","year":"2014","unstructured":"Sharma P, Madi HA, Bonshek R, Morgan SJ. Cloudy corneas as an initial presentation of multiple myeloma. Clin Ophthalmol. 2014, 8:813-7. 10.2147\/OPTH.S49283","journal-title":"Clin Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_422_23","article-title":"DICED - anti-depressant drug-induced corneal endothelial deposits","volume":"65","author":"Christy J","year":"2023","unstructured":"Christy J, Nair M, Tagare S. DICED - anti-depressant drug-induced corneal endothelial deposits. Indian J Psychiatry. 2023, 65:1084-6. 10.4103\/indianjpsychiatry.indianjpsychiatry_422_23","journal-title":"Indian J Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2385497","article-title":"Eye disorders associated with selective serotonin reuptake inhibitors: a real-world disproportionality analysis of FDA adverse event reporting system","volume":"24","author":"Li J","year":"2025","unstructured":"Li J, Zhong R, Guo Y, Zhang F. Eye disorders associated with selective serotonin reuptake inhibitors: a real-world disproportionality analysis of FDA adverse event reporting system. Expert Opin Drug Saf. 2025, 24:853-63. 10.1080\/14740338.2024.2385497","journal-title":"Expert Opin Drug Saf"},{"key":"ref20","article-title":"Identify the ocular side effects of systemic medications","volume":"145","author":"Muchnick BG","year":"2008","unstructured":"Muchnick BG. Identify the ocular side effects of systemic medications. Rev Optom. 2008, 145:60.","journal-title":"Rev Optom"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418080-00001","article-title":"SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms","volume":"18","author":"Costagliola C","year":"2004","unstructured":"Costagliola C, Parmeggiani F, Sebastiani A. SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms. CNS Drugs. 2004, 18:475-84. 10.2165\/00023210-200418080-00001","journal-title":"CNS Drugs"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/24750573.2019.1673944","article-title":"Early effects of selective serotonin reuptake inhibitors on cornea and lens density in patients with depression","volume":"29","author":"Karak\u00fc\u00e7\u00fck Y","year":"2019","unstructured":"Karak\u00fc\u00e7\u00fck Y, Beyoglu A, \u00c7\u00f6mez A, Orhan F\u00d6, Demir M. Early effects of selective serotonin reuptake inhibitors on cornea and lens density in patients with depression. Psychiatry Clin Psychopharmacol. 2019, 29:387-93. 10.1080\/24750573.2019.1673944","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.18-25572","article-title":"Selective serotonin reuptake inhibitors aggravate depression-associated dry eye via activating the NF-\u03baB pathway","volume":"60","author":"Zhang X","year":"2019","unstructured":"Zhang X, Yin Y, Yue L, Gong L. Selective serotonin reuptake inhibitors aggravate depression-associated dry eye via activating the NF-\u03baB pathway. Invest Ophthalmol Vis Sci. 2019, 60:407-19. 10.1167\/iovs.18-25572","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3233\/JRS-210018","article-title":"Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants","volume":"33","author":"Healy D","year":"2022","unstructured":"Healy D, Mangin D, Lochhead J. Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants. Int J Risk Saf Med. 2022, 33:37-47. 10.3233\/JRS-210018","journal-title":"Int J Risk Saf Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.119","article-title":"SSRI-associated optic neuropathy","volume":"29","author":"Lochhead J","year":"2015","unstructured":"Lochhead J. SSRI-associated optic neuropathy. Eye (Lond). 2015, 29:1233-5. 10.1038\/eye.2015.119","journal-title":"Eye (Lond)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1999.0773","article-title":"Effect of fluoxetine on intraocular pressure in the rabbit","volume":"70","author":"Costagliola C","year":"2000","unstructured":"Costagliola C, Mastropasqua L, Capone D, Verolino M, Ciancaglini M, Pisanti N. Effect of fluoxetine on intraocular pressure in the rabbit. Exp Eye Res. 2000, 70:551-5. 10.1006\/exer.1999.0773","journal-title":"Exp Eye Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1996.26","article-title":"Subhyaloid haemorrhage with fluoxetine","volume":"10","author":"Wilmshurst PT","year":"1996","unstructured":"Wilmshurst PT, Kumar AV. Subhyaloid haemorrhage with fluoxetine. Eye (Lond). 1996, 10:141. 10.1038\/eye.1996.26","journal-title":"Eye (Lond)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftale.2024.04.010","article-title":"Presumed fluoxetine maculopathy","volume":"99","author":"Benito NM","year":"2024","unstructured":"Benito NM, Blasco Palacio PB, Garc\u00eda IR. Presumed fluoxetine maculopathy. Arch Soc Esp Oftalmol (Engl Ed). 2024, 99:344-6. 10.1016\/j.oftale.2024.04.010","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5958\/2394-2061.2017.00001.5","article-title":"Fluoxetine-induced blurring of vision: a rare ocular side effect","volume":"8","author":"Deka N","year":"2017","unstructured":"Deka N, Kumari R. Fluoxetine-induced blurring of vision: a rare ocular side effect. Open J Psychiatry Allied Sci. 2017, 8:163-4. 10.5958\/2394-2061.2017.00001.5","journal-title":"Open J Psychiatry Allied Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451281-a-rare-case-of-fluoxetine-induced-vortex-keratopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:25:59Z","timestamp":1770229559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451281-a-rare-case-of-fluoxetine-induced-vortex-keratopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.102975","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}